Create a free QxMD account to receive personalized paper recommendations, relevant to your practice.

Get Started

COMMENT

EDITORIAL

Means, motive, and opportunity: SDH mutations are suspects in pituitary tumors

Albert Beckers

Journal of Clinical Endocrinology and Metabolism 2013, 98 (6): 2274-6

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma. Trisha Dwight, Kirsty Mann, Diana E Benn, Bruce G Robinson, Penny McKelvie, Anthony J Gill, Ingrid Winship, Roderick J Clifton-Bligh Journal of Clinical Endocrinology and Metabolism 2013, 98 (6): E1103-8

Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. O Gimm, M Armanios, H Dziema, H P Neumann, C Eng Cancer Research 2000 December 15, 60 (24): 6822-5

Mitochondrial function and content in pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers. E Rapizzi, T Ercolino, L Canu, V Giaché, M Francalanci, C Pratesi, A Valeri, M Mannelli Endocrine-related Cancer 2012, 19 (3): 261-9

The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients. Jean-Pierre Bayley, Anneliese E M Grimbergen, Patrick A van Bunderen, Michiel van der Wielen, Henricus P Kunst, Jacques W Lenders, Jeroen C Jansen, Robin P F Dullaart, Peter Devilee, Eleonora P Corssmit, Annette H Vriends, Monique Losekoot, Marjan M Weiss BMC Medical Genetics 2009, 10: 34

Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? Paraskevi Xekouki, Karel Pacak, Madson Almeida, Christopher A Wassif, Pierre Rustin, Maria Nesterova, Maria de la Luz Sierra, Joey Matro, Evan Ball, Monalisa Azevedo, Anelia Horvath, Charalampos Lyssikatos, Martha Quezado, Nicholas Patronas, Barbara Ferrando, Barbara Pasini, Aristides Lytras, George Tolis, Constantine A Stratakis Journal of Clinical Endocrinology and Metabolism 2012, 97 (3): E357-66

Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/pheochromocytoma (PGL/PCC). Ulrich Müller Neurogenetics 2011, 12 (3): 175-81

Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma. Eijiro Nakamura, William G Kaelin Endocrine Pathology 2006, 17 (2): 97-106

Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications. Justine A Barletta, Jason L Hornick Advances in Anatomic Pathology 2012, 19 (4): 193-203

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Anthony J Gill, Diana E Benn, Angela Chou, Adele Clarkson, Anita Muljono, Goswin Y Meyer-Rochow, Anne Louise Richardson, Stan B Sidhu, Bruce G Robinson, Roderick J Clifton-Bligh Human Pathology 2010, 41 (6): 805-14

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. Jean-Pierre Bayley, Ivonne van Minderhout, Marjan M Weiss, Jeroen C Jansen, Peter H N Oomen, Fred H Menko, Barbara Pasini, Barbara Ferrando, Nora Wong, Lesley C Alpert, Rosie Williams, Edward Blair, Peter Devilee, Peter E M Taschner BMC Medical Genetics 2006, 7: 1

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Means, motive, and opportunity: SDH mutations are suspects in pituitary tumors

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips